Lactobacillus-Associated Spontaneous Bacterial Peritonitis in a Liver Cirrhosis Patient on Probiotics
| Autor: | Venkata Satish Dontaraju, Kushal Patel, Lintu Ramachandran |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Cirrhosis medicine.drug_class liver cirrhosis Antibiotics Infectious Disease 030204 cardiovascular system & hematology Tazobactam Gastroenterology 03 medical and health sciences 0302 clinical medicine Spontaneous bacterial peritonitis Internal medicine medicine Paracentesis Hepatic encephalopathy medicine.diagnostic_test business.industry General Engineering medicine.disease paracentesis lactobacillus spontaneous bacterial peritonitis probiotics Ceftriaxone Other business sbp 030217 neurology & neurosurgery Piperacillin medicine.drug |
| Zdroj: | Cureus |
| ISSN: | 2168-8184 |
| Popis: | The efficacy of over the counter probiotics has been an area of scientific debate. While the benefits of probiotics are heavily disputed, probiotics are considered generally safe. We present a case of a liver cirrhosis patient, who presented with hepatic encephalopathy. The patient was taking daily probiotics and receiving weekly therapeutic paracentesis. His workup revealed spontaneous bacterial peritonitis (SBP). Despite starting the patient on empiric ceftriaxone and vancomycin, the patient's leukocytosis did not improve. The paracentesis fluid and blood cultures grew Lactobacillus gasseri. Antibiotics were switched to piperacillin/tazobactam, after which the patient improved clinically. The case highlights the importance of vigilance in using probiotics, especially in liver cirrhosis patients. Also, patients with Lactobacillus-associated SBP may not improve with empiric antibiotic treatment of cephalosporins. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|